Aptamers Market by Application and Geography - Forecast and Analysis 2022-2026

The aptamers market share is expected to increase by USD 1.31 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 27.70%.

This aptamers market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers aptamers market segmentation by application (therapeutics development, research and development, diagnostic, and others) and geography (North America, Europe, Asia, and ROW). The aptamers market report also offers information on several market vendors, including Aptagen LLC, Aptamer Group Ltd., Aptamer Sciences Inc, APTATARGETS SL, Base Pair Biotechnologies Inc., Kaneka Corp., Maravai LifeSciences Holdings Inc., NeoVentures Biotechnology Inc, SomaLogic Inc, and Vivonics Inc among others.

What will the Aptamers Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Aptamers Market Size for the Forecast Period and Other Important Statistics

 

Aptamers Market: Key Drivers and Challenges

The increasing incidence of cancer boosting demand for novel diagnostics is notably driving the aptamers market growth, although factors such as inherent challenges associated with oligonucleotide therapies may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the aptamers industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Aptamers Market Driver

The prevalence of chronic diseases such as cancer, cardiovascular diseases (CVD), diabetes, and autoimmune diseases is growing due to factors such as the increase in pollution and the adoption of a sedentary lifestyle. The growing incidence of cancer has increased the need for novel therapeutics. To accurately detect cancer cells, diagnostic tests primarily rely on antibody-antigen binding assays, which may have a few limitations, such as the inability to detect minor antibodies. Aptamers are better probes than monoclonal antibodies (mAbs). Aptamers are short single-stranded deoxyribonucleic acid (ssDNA) or ribonucleic acid (RNA) oligonucleotides, which recognize the target with high specificity and sensitivity. Unlike mAbs, which are stable only at low temperatures, aptamers are stable at ambient temperatures. Aptamers can be produced in vitro and are cost-effective compared to mAbs, which require animal hosts. Thus, aptamers can have high selectivity, affinity, and stability, and they can be used as molecular probes in bioanalysis and biomedicine. Hence, the rising prevalence of chronic and infectious diseases increases the demand for novel therapies, thus benefiting the global aptamers market. 

Key Aptamers Market Challenge

Oligonucleotide therapy has the potential to improve biomedical research. Its applications are primarily in academic research and are projected to be promising in publications. However, the lack of transitional research dealing with real-world medical and scientific challenges affects the market. In several publications, oligonucleotide applications include single-cell mRNA that can act as potential therapeutic agents. However, the translation of this technology from academia to industry is yet to be explored. Another challenge is the administration of RNA-based drugs. RNAi and antisense molecules can be administered by intravenous or other similar methods. As these therapeutics cannot be administered orally, doctors or registered nurses must administer these drugs. In addition, errors in administration can lead to serious health concerns as non-specific mRNA may be targeted. These challenges will affect the adoption of aptamers.

This aptamers market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Who are the Major Aptamers Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

 

• Aptagen LLC
• Aptamer Group Ltd.
• Aptamer Sciences Inc
• APTATARGETS SL
• Base Pair Biotechnologies Inc.
• Kaneka Corp.
• Maravai LifeSciences Holdings Inc.
• NeoVentures Biotechnology Inc
• SomaLogic Inc
• Vivonics Inc

 

This statistical study of the aptamers market encompasses successful business strategies deployed by the key vendors. The aptamers market is fragmented and the vendors are deploying various organic and inorganic growth strategies to compete in the market.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The aptamers market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies. 

Which are the Key Regions for Aptamers Market?

For more insights on the market share of various regions Request for a FREE sample now!

49% of the market's growth will originate from North America during the forecast period. The US and Canada are the key markets for aptamers in North America. However, the market growth rate in this region will be slower than the growth of the market in Asia and Europe.

The presence of a well-established healthcare system and high investments in healthcare research and testing will facilitate the aptamers market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

What are the Revenue-generating Application Segments in the Aptamers Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The aptamers market share growth by the therapeutics development segment will be significant due to the increasing number of clinical trials evaluating aptamers for new therapies and collaborations among vendors of aptamers and prominent pharmaceutical and biotechnology companies. For most therapeutic purposes, aptamers are truncated to reduce synthesis costs, modified at the sugars and capped at their termini to increase nuclease resistance, and conjugated to polyethylene glycol or another entity to reduce renal filtration rates. 

This report provides an accurate prediction of the contribution of all the segments to the growth of the aptamers market size and actionable market insights on post COVID-19 impact on each segment.

 

Aptamers Market Scope
Report Coverage	Details
Page number	120
Base year	2021
Forecast period	2022-2026
Growth momentum & CAGR	Accelerate at a CAGR of 27.70%
Market growth 2022-2026	$ 1.31 billion
Market structure	Fragmented
YoY growth (%)	26.68
Regional analysis	North America, Europe, Asia, and ROW
Performing market contribution	North America at 49%
Key consumer countries	US, Germany, UK, Canada, and China
Competitive landscape	Leading companies, Competitive strategies, Consumer engagement scope
Key companies profiled	Aptagen LLC, Aptamer Group Ltd., Aptamer Sciences Inc, APTATARGETS SL, Base Pair Biotechnologies Inc., Kaneka Corp., Maravai LifeSciences Holdings Inc., NeoVentures Biotechnology Inc, SomaLogic Inc, and Vivonics Inc
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Aptamers Market Report?

• CAGR of the market during the forecast period 2022-2026
• Detailed information on factors that will drive aptamers market growth during the next five years
• Precise estimation of the aptamers market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the aptamers industry across North America, Europe, Asia, and ROW
• A thorough analysis of the market's competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of aptamers market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch